Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agex Therapeutics Inc (NY: AGE )

1.380 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Jun 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.380
Bid (Size) 1.260 (9)
Ask (Size) 1.450 (3)
Prev. Close 1.380
Today's Range 1.380 - 1.380
52wk Range 0.7361 - 3.930
Shares Outstanding 37,935,088
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter... 
From Business Wire News Releases
AgeX Therapeutics Reports Fourth Quarter and Annual 2020 Financial Results and Provides Business Update
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the fourth... 
From Business Wire News Releases

Performance

YTD
-12.66%
-12.66%
1 Month
+0.73%
+0.73%
3 Month
-36.70%
-36.70%
6 Month
-22.03%
-22.03%
1 Year
+28.97%
+28.97%

More News

Read More
AgeX Announces Preprint Article Relating to Regeneration, Aging, and Cancer
From Business Wire News Releases
AgeX Therapeutics to Collaborate with The Ohio State University to Generate Proof-of-Concept Animal Data for AgeX’s Brown Adipose Tissue (BAT) Cell Therapy Candidate for Diabetes and Obesity
From Business Wire News Releases
AgeX Therapeutics and LyGenesis to Negotiate Merger Agreement
From Business Wire News Releases
AgeX Therapeutics, Inc. Announces That Its Annual Meeting of Stockholders Will Be Conducted Online Only
From Business Wire News Releases
AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
From Business Wire News Releases
AgeX Therapeutics Sublicenses Stem Cell Line ESI-053 to ImStem Biotechnology for Development of Cell Therapy Candidate IMS001 for COVID-19 and Acute Respiratory Distress Syndrome
From Business Wire News Releases
Longevity Stocks
Tags ETFs Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Mid-Day Market Update: Gold Gains 2%; ShiftPixy Shares Plunge
Tags PIXY OEG MVIS
From Benzinga
US Stock Market Weekly Review Oct. 5-9
Tags Stocks / Equities
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.